ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,764 | -78.8% | 48,420 | -68.3% | 0.00% | -75.0% |
| Q2 2023 | $27,178 | -1.4% | 152,516 | -8.7% | 0.00% | 0.0% |
| Q1 2023 | $27,567 | -22.3% | 167,112 | -25.8% | 0.00% | -33.3% |
| Q4 2022 | $35,474 | -99.9% | 225,258 | -16.9% | 0.01% | -14.3% |
| Q3 2022 | $40,844,000 | -90.8% | 271,197 | -90.0% | 0.01% | -87.5% |
| Q2 2022 | $445,351,000 | -26.1% | 2,709,115 | +0.0% | 0.06% | -8.2% |
| Q1 2022 | $602,874,000 | -6.8% | 2,707,841 | -0.6% | 0.06% | +5.2% |
| Q4 2021 | $646,880,000 | +2.8% | 2,725,540 | +1.1% | 0.06% | -1.7% |
| Q3 2021 | $629,078,000 | +28.6% | 2,695,510 | +13.4% | 0.06% | +31.1% |
| Q2 2021 | $489,108,000 | -7.6% | 2,376,620 | -7.8% | 0.04% | -15.1% |
| Q1 2021 | $529,587,000 | -6.5% | 2,577,820 | -2.4% | 0.05% | -8.6% |
| Q4 2020 | $566,332,000 | +16.7% | 2,640,364 | -0.6% | 0.06% | +3.6% |
| Q3 2020 | $485,410,000 | -1.3% | 2,655,997 | -0.4% | 0.06% | -9.7% |
| Q2 2020 | $491,573,000 | -8.9% | 2,667,100 | -0.3% | 0.06% | -27.1% |
| Q1 2020 | $539,580,000 | +11.6% | 2,674,231 | +3.5% | 0.08% | +34.9% |
| Q4 2019 | $483,661,000 | +15.7% | 2,584,762 | -1.3% | 0.06% | +6.8% |
| Q3 2019 | $417,898,000 | -52.3% | 2,618,410 | -24.7% | 0.06% | -52.0% |
| Q2 2019 | $876,365,000 | +29.0% | 3,478,883 | +22.6% | 0.12% | +23.0% |
| Q1 2019 | $679,328,000 | +6.4% | 2,838,458 | +2.1% | 0.10% | -7.4% |
| Q4 2018 | $638,422,000 | +729.6% | 2,780,219 | +921.5% | 0.11% | +881.8% |
| Q3 2018 | $76,952,000 | +3.5% | 272,157 | +7.5% | 0.01% | 0.0% |
| Q2 2018 | $74,336,000 | +22.8% | 253,144 | +5.5% | 0.01% | +10.0% |
| Q1 2018 | $60,535,000 | +20.7% | 239,838 | +3.3% | 0.01% | +25.0% |
| Q4 2017 | $50,148,000 | +13.9% | 232,168 | -2.0% | 0.01% | 0.0% |
| Q3 2017 | $44,029,000 | +4.9% | 236,905 | -2.6% | 0.01% | 0.0% |
| Q2 2017 | $41,960,000 | +13.4% | 243,249 | +0.4% | 0.01% | +14.3% |
| Q1 2017 | $37,005,000 | +10.4% | 242,341 | +6.6% | 0.01% | 0.0% |
| Q4 2016 | $33,507,000 | +21.3% | 227,400 | +4.0% | 0.01% | +16.7% |
| Q3 2016 | $27,633,000 | +26.0% | 218,650 | +12.4% | 0.01% | +20.0% |
| Q2 2016 | $21,924,000 | +16.0% | 194,450 | +7.1% | 0.01% | +25.0% |
| Q1 2016 | $18,899,000 | +20.4% | 181,550 | +30.5% | 0.00% | +33.3% |
| Q4 2015 | $15,692,000 | +15.3% | 139,140 | +11.9% | 0.00% | 0.0% |
| Q3 2015 | $13,611,000 | +18.5% | 124,300 | +3.5% | 0.00% | +50.0% |
| Q2 2015 | $11,489,000 | +23.2% | 120,100 | +20.0% | 0.00% | 0.0% |
| Q1 2015 | $9,323,000 | +20.2% | 100,100 | +5.7% | 0.00% | 0.0% |
| Q4 2014 | $7,756,000 | +35.5% | 94,700 | +6.2% | 0.00% | +100.0% |
| Q3 2014 | $5,725,000 | +6.1% | 89,200 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $5,394,000 | +11.2% | 88,700 | +9.5% | 0.00% | 0.0% |
| Q1 2014 | $4,850,000 | -52.5% | 81,000 | -49.4% | 0.00% | 0.0% |
| Q4 2013 | $10,206,000 | +99.8% | 160,200 | +113.0% | 0.00% | 0.0% |
| Q3 2013 | $5,108,000 | -51.1% | 75,200 | -48.1% | 0.00% | 0.0% |
| Q2 2013 | $10,448,000 | – | 145,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |